Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects

On the front lines of the opioid epidemic: Rescue by naloxone

(2018) Phil Skolnick   EUROPEAN JOURNAL OF PHARMACOLOGY

Pharmacokinetics of a new, nasal formulation of naloxone

(2017) Ida Tylleskar et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Feeding Releases Endogenous Opioids in Humans

(2017) Jetro J. Tuulari et al.   JOURNAL OF NEUROSCIENCE

Opioid Release after High-Intensity Interval Training in Healthy Human Subjects

(2017) Tiina Saanijoki et al.   NEUROPSYCHOPHARMACOLOGY

Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose

(2016) Philip Krieter et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating

(2016) Joonas Majuri et al.   NEUROPSYCHOPHARMACOLOGY

Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability

(2016) Tomi Karjalainen et al.   Social Cognitive and Affective Neuroscience

Obesity Is Associated with Decreased  -Opioid But Unaltered Dopamine D2 Receptor Availability in the Brain

(2015) H. K. Karlsson et al.   JOURNAL OF NEUROSCIENCE

Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers

(2015) Inge Mick et al.   NEUROPSYCHOPHARMACOLOGY

A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling

(2015) Leena Kovanen et al.   EUROPEAN ADDICTION RESEARCH

Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI

(2013) C. Y. Sander et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Gambling disorders

(2011) David C Hodgins et al.   LANCET

Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans

(2011) E A Rabiner et al.   MOLECULAR PSYCHIATRY

A linear model for estimation of neurotransmitter response profiles from dynamic PET data

(2011) Marc D. Normandin et al.   NEUROIMAGE

Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study

(2010) Jon E. Grant et al.   BRITISH JOURNAL OF PSYCHIATRY

Positron Emission Tomography Measures of Endogenous Opioid Neurotransmission and Impulsiveness Traits in Humans

(2009) Tiffany M. Love et al.   ARCHIVES OF GENERAL PSYCHIATRY

Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [11C]diprenorphine PET study

(2009) Tim M. Williams et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A Double-Blind, Placebo-Controlled Study of the Opiate Antagonist Naltrexone in the Treatment of Pathological Gambling Urges

(2009) Jon E. Grant et al.   JOURNAL OF CLINICAL PSYCHIATRY

Measurement of central µ-opioid receptor binding in vivo with PET and [11C]carfentanil: a test–retest study in healthy subjects

(2008) Jussi Hirvonen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING